ORA:EURONEXT PARISOrange SA Analysis
Data as of 2026-08-28 - not real-time
$102.60
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Ormat Technologies, Inc. is priced at $102.60 and its moving averages line up in bearish order, the shorter trailing the longer. It has lost 2.0% over the past 30 days. RSI sits at 40.7, which reads as neutral, and MACD momentum is bearish. Recent trading has carved out support near $95.08 and resistance around $117.01.
The shares look fair, trading on 50.3 times earnings above a sector average of 19.4. Analyst price targets sit 29.5% above the current price. Revenue is growing at 10.6% on a 10.7% profit margin. The 0.46% dividend yield looks covered by current payout levels.
Risk scores 7 out of 10, which is elevated for this asset class. With 30-day volatility of 44.0%, a beta of 0.89 and a maximum drawdown of 35.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons diverge: sell near-term but hold on a long view, at 3/10 conviction over the longer horizon.
The shares look fair, trading on 50.3 times earnings above a sector average of 19.4. Analyst price targets sit 29.5% above the current price. Revenue is growing at 10.6% on a 10.7% profit margin. The 0.46% dividend yield looks covered by current payout levels.
Risk scores 7 out of 10, which is elevated for this asset class. With 30-day volatility of 44.0%, a beta of 0.89 and a maximum drawdown of 35.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons diverge: sell near-term but hold on a long view, at 3/10 conviction over the longer horizon.
Top Market Events
In early August 2026, Ormat Technologies, Inc.Ormat Technologies ORA possesses the right combination of the two key ingredients for a likely earnings beat in its...Ormat Technologies, Inc. NYSE:ORA is one of the 15 Best Power Generation Stocks To Buy For Data Center Demand. On May...
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 115.62
- MACD momentum is negative
Medium Term
1–3 yearsCautious
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 50.3 versus sector average of 19.4
- Trading below the 200-day average of 115.62
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 50.3 versus sector average of 19.4
- Analyst targets imply +29.5% versus the current price
- Revenue growth of +10.6%
Key Metrics & Analysis
Financial Health
Revenue Growth10.60%
Profit Margin10.66%
P/E Ratio50.3
ROE4.78%
ROA2.04%
Debt/Equity124.34
P/B Ratio2.4
Op. Cash Flow$279.4M
Free Cash Flow$-318099008
Industry P/E19.4
Technical Analysis
TrendBearish
RSI40.7
Support$95.08
Resistance$117.01
MA 20$107.63
MA 50$108.58
MA 200$115.62
MACDBearish
VolumeDecreasing
Fear & Greed Index95.25
Valuation
Fair Value$16.70
Target Price$132.83
Upside/Downside29.47%
GradeFair
TypeGrowth
Dividend Yield0.46%
Risk Assessment
Beta0.89
Volatility43.96%
Sector RiskLow
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.